Affinia Therapeutics Inc., of Waltham, Mass., appointed Elliott Sigal to its board.
Arix Bioscience plc, of London, appointed Christian Schetter managing director. It named Ruth Atherton, Andreas Busch, Trevor Jones and KJ Patel to its scientific advisory board, with Jones serving as chair. Executive Chair Naseem Amin will chair its board investment committee.
Constellation Pharmaceuticals Inc., of Cambridge, Mass., appointed Jeffrey Humphrey chief medical officer.
Dalcor Pharmaceuticals, of Montreal, appointed Diane E. Sullivan chief commercial officer.
NGM Biopharmaceuticals Inc., of South San Francisco, appointed Carole Ho to its board.
Summit Therapeutics plc, of Oxford U.K., appointed Michael Donaldson chief financial officer.
Valo Therapeutics Ltd., of Oxford, U.K., appointed Mai-Britt Zocca to its board.